Latest Breaking News On - Etienne sokal - Page 1 : comparemela.com

Belgium: Cellaïon appoints new CEO to drive clinical and commercial development

Belgium: Cellaïon appoints new CEO to drive clinical and commercial development
laingbuissonnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from laingbuissonnews.com Daily Mail and Mail on Sunday newspapers.

Etienne sokalJames neil phillips

Catalent acquires facility in Belgium for commercial-scale plasmid DNA manufacturing

Privacy Overview This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience. Necessary

Waals gewestManja boermanEtienne sokalHepatic cell therapy supportAdelphi geneticsCatalent cellடெல்பி ஜெநெடிக்ஸ்

Catalent Acquires Additional Facility at its Gosselies, Belgium Campus for Commercial-Scale Plasmid DNA Manufacturing

Catalent Acquires Additional Facility at its Gosselies, Belgium Campus for Commercial-Scale Plasmid DNA Manufacturing Share Article Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, and Promethera Biosciences, the world leader in advanced therapy development for severe liver diseases, today announced that Catalent has acquired Promethera’s cell therapy manufacturing subsidiary, Hepatic Cell Therapy Support SA (HCTS), including its 32,400 square-foot (3,010 square-meter) facility in Gosselies, Belgium. The facility will accommodate Catalent’s new commercial-scale plasmid DNA (pDNA) manufacturing and will provide the opportunity for the immediate growth of Catalent’s pDNA service offering, which was recently acquired from Delphi Genetics to support the growing cell and gene therapy pipeline.

United statesNew jerseyWaals gewestEtienne sokalPromethera biosciencesManja boermanEuropean centerHepatic cell therapy supportAdelphi geneticsCatalent cellGene therapyஒன்றுபட்டது மாநிலங்களில்புதியது ஜெர்சிஐரோப்பிய மையம்டெல்பி ஜெநெடிக்ஸ்கீந் சிகிச்சை